利用全基因组数据区分阿片类使用与依赖:PGC 41,176 人研究
该研究基于精神病基因组学联盟(PGC)41,176 名欧洲与非洲裔参与者,比较阿片类依赖(OD)、阿片类暴露对照与未暴露对照。结果显示 rs9291211 与阿片类暴露相关,SDCCAG8 与暴露相关,rs201123820 在非洲裔中与 OD 相关;基于风险容忍与神经质的多基因风险评分分别与 OD 和暴露呈不同关联,提示依赖与暴露的遗传基础存在差异。
要点
- rs9291211 与阿片类暴露相关,并调控 SLC30A9 与 BEND4 的脑组织转录谱。
- SDCCAG8 与阿片类暴露相关,既往与教育程度、冒险行为及精神分裂症相关。
- 基于风险容忍的多基因风险评分与 OD 和暴露均正相关,而神经质评分仅与 OD 相关。
核心结论
- 阿片类依赖与阿片类暴露的遗传关联模式不同,研究成瘾时需明确对照定义。
研究设计与样本
- 全基因组关联分析比较 4503 例 OD、4173 例阿片类暴露对照与 32,500 例未暴露对照,含欧洲与非洲裔参与者。
- 基于风险容忍(n=466,571)与神经质(n=390,278)的 GWAS 构建多基因风险评分并检验其与 OD 和暴露的关联。
- 对 rs9291211 在英国生物库(N>360,000)中进行表型组扫描。
主要发现
- rs9291211 与阿片类暴露相关(欧洲裔 z=-5.39,p=7.2×10⁻⁸)。
- SDCCAG8 在基因水平与阿片类暴露相关(欧洲裔+非洲裔 z=4.69,p=10⁻⁶)。
- rs201123820 在非洲裔中与 OD 对未暴露对照的差异达全基因组显著(z=5.55,p=2.9×10⁻⁸)。
- 风险容忍 PRS 与 OD(OD 对未暴露对照 p=8.1×10⁻⁵;OD 对暴露对照 p=0.054)及暴露(暴露对未暴露对照 p=3.6×10⁻⁵)正相关。
- 神经质 PRS 与 OD 正相关(OD 对未暴露对照 p=3.2×10⁻⁵;OD 对暴露对照 p=0.002),与暴露无关(p=0.67)。
关键数值与推荐
- rs9291211 与英国生物库中膳食补充剂使用倾向相关(p=1.68×10⁻⁸)。
- rs201123820 与英国生物库中肌肉骨骼疾病相关(p=4.88×10⁻⁷)。
临床怎么用
- 在成瘾遗传研究中应区分阿片类暴露与依赖,并谨慎选择对照人群。
- 多基因风险评分可提示不同遗传维度与 OD 或暴露的关联差异,但尚未用于临床诊断。
局限性
- 原文摘要未列出研究的全部局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To provide insights into the biology of opioid dependence (OD) and opioid use (i.e., exposure, OE), we completed a genome-wide analysis comparing 4503 OD cases, 4173 opioid-exposed controls, and 32,500 opioid-unexposed controls, including participants of European and African descent (EUR and AFR, respectively). Among the variants identified, rs9291211 was associated with OE (exposed vs. unexposed controls; EUR z = -5.39, p = 7.2 × 10-8). This variant regulates the transcriptomic profiles of SLC30A9 and BEND4 in multiple brain tissues and was previously associated with depression, alcohol consumption, and neuroticism. A phenome-wide scan of rs9291211 in the UK Biobank (N > 360,000) found association of this variant with propensity to use dietary supplements (p = 1.68 × 10-8). With respect to the same OE phenotype in the gene-based analysis, we identified SDCCAG8 (EUR + AFR z = 4.69, p = 10-6), which was previously associated with educational attainment, risk-taking behaviors, and schizophrenia. In addition, rs201123820 showed a genome-wide significant difference between OD cases and unexposed controls (AFR z = 5.55, p = 2.9 × 10-8) and a significant association with musculoskeletal disorders in the UK Biobank (p = 4.88 × 10-7). A polygenic risk score (PRS) based on a GWAS of risk-tolerance (n = 466,571) was positively associated with OD (OD vs. unexposed controls, p = 8.1 × 10-5; OD cases vs. exposed controls, p = 0.054) and OE (exposed vs. unexposed controls, p = 3.6 × 10-5). A PRS based on a GWAS of neuroticism (n = 390,278) was positively associated with OD (OD vs. unexposed controls, p = 3.2 × 10-5; OD vs. exposed controls, p = 0.002) but not with OE (p = 0.67). Our analyses highlight the difference between dependence and exposure and the importance of considering the definition of controls in studies of addiction.
引用
- Polimanti R, Walters RK, Johnson EC, et al. Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium. Mol Psychiatry. 2020. PMID: 32099098. doi:10.1038/s41380-020-0677-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。